Measurement of breathlessness in patients with malignant pleural effusions Eleanor K. Mishra Pleural Diseases and Mesothelioma (G Lee, Section Editor) 14 January 2016 Pages: 1 - 6
Manometry in pleural drainage: essential practice or over-rated gadget? Fayez KheirFabien Maldonado Pleural Diseases and Mesothelioma (G Lee, Section Editor) 15 January 2016 Pages: 7 - 12
BAP1 mutations in mesothelioma: advances and controversies Sophie SneddonJenette Creaney Pleural Diseases and Mesothelioma (G Lee, Section Editor) 13 January 2016 Pages: 13 - 19
Nutrition, exercise, and complementary medicine: potential role in mesothelioma? Sanjeevan MuruganandanEmily JefferyY. C. Gary Lee Pleural Diseases and Mesothelioma (G Lee, Section Editor) 19 January 2016 Pages: 20 - 27
Pleural disease in infants and children: management updates Jennifer SoaresGregory J. Redding Pleural Diseases and Mesothelioma (G Lee, Section Editor) 28 January 2016 Pages: 28 - 34
New insights on pleural fluid formation: potential translational targets Malamati VrekaLaura V. KlotzGeorgios T. Stathopoulos Pleural Diseases and Mesothelioma (G Lee, Section Editor) 18 January 2016 Pages: 35 - 39
Harnessing the antitumor immunity cycle to treat lung cancer Myriam DelaunayJulien MazièresNicolas Guibert Lung Cancer (C Mascaux, Section Editor) 11 February 2016 Pages: 40 - 48
New oncogenes drivers in lung cancer—new therapeutic targets Pascale TomasiniFrederic FinaFabrice Barlesi Lung Cancer (C Mascaux, Section Editor) 04 February 2016 Pages: 49 - 56
ROS-1 rearrangements in non-small cell lung cancer (NSCLC): a new target for a small subset of patients but a giant leap in therapeutics Solenn BrosseauYoussef OulkhouirGérard Zalcman Lung Cancer (C Mascaux, Section Editor) 04 February 2016 Pages: 57 - 62
